ERAS

Erasca, Inc. Common Stock
$13.82 +7.63%

Recent alerts on ERAS

All signals →
News Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800%
3d ago
News Why Is Cancer Drug Developer Erasca Stock Trading Lower Monday?
14d ago
News Erasca Narrows Loss 46% in Fiscal Q2
14d ago
Short volume Short volume 76% of volume (3.9σ)
17d ago
News Erasca teams up with Merck to test ERAS-0015 with Keytruda, shares jump
22d ago
News Revolution Medicines wins FDA nod to provide early access to cancer therapy
32d ago
Scanner Large down move: 48.3% (2.7x normal daily movement)
33d ago
News Cancer Drug Developer Erasca Sinks by Record 55% After Patient Death
35d ago
News Revolution Medicines rival Erasca falls after early-stage trial data for cancer therapy
35d ago
SEC filing ERAS Reports $12B Revenue, $3.4B Net Income, Announces $20B Buyback
35d ago
SEC filing ERAS Reports $12M Revenue, $0.05 EPS, Announces $20M Buyback, RAS-Mutant Data Call, RevMed IP Threat
36d ago
SEC filing ERAS Narrows ERAS-0015 Monotherapy Readout to Mid-May 2026, Advancing Pan-RAS Glue Data from AURORAS-1/JYP0015M101 Trials
42d ago
SEC filing ERAS Reports $259M Upsized Financing, $434M Cash Runway to H2 2028, RAS Glue ERAS-0015 Shows Partial Responses, Phase 1 Data H1 2026, ERAS-4001 Data H2 2026, Expanded China Rights
81d ago
Insider trade Sale by Shannon Morris (Chief Medical Officer)
88d ago
News Tango rises after Q4 results, clinical pact with Erasca
88d ago
News Axalta Coating Systems misses top-line and bottom-line estimates; initiates Q1 and FY26 outlook
112d ago
News Arnhold More Than Doubles Axalta Coatings Systems Share Holding
112d ago
News Axalta Coating Systems Q4 2025 Earnings Preview
113d ago
Short volume Short volume 78% of volume (4.6σ)
123d ago
News Erasca prices $225M stock offering at $10 per share
131d ago
News Erasca Announces Pricing of Upsized Public Offering of Common Stock
131d ago
News Erasca Announces Proposed Public Offering of $150 Million of Common Stock
132d ago
News Erasca plans $150M public stock offering
132d ago
News Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
139d ago
News Revolution Medicines jumps on report AbbVie nears takeover
145d ago

Get push alerts for ERAS

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS